A history of being prescribed controlled substances and risk of drug overdose death

Pain Medicine

Volumn 13, Issue 1, 2012, Pages 87-95

  Paulozzi, Leonard J ^a   Kilbourne, Edwin M ^b   Shah, Nina G ^c   Nolte, Kurt B ^d   Desai, Hema A ^e   Landen, Michael G ^c   Harvey, William ^f   Loring, Larry D ^f  

^a NATIONAL CENTER FOR INJURY PREVENTION AND CONTROL   (United States)

^b Martin Blanck and Associates   (United States)

^c NEW MEXICO DEPARTMENT OF HEALTH   (United States)

^d UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^e BOOZ ALLEN HAMILTON   (United States)

^f New Mexico Prescription Monitoring Program   (United States)

Author keywords

Abuse; Analgesic; Opioid; Pain Management; Prescriptions; Safety

Indexed keywords

CODEINE; DIHYDROCODEINE; HYDROCODONE; HYDROMORPHONE; HYPNOTIC AGENT; METHADONE; MORPHINE; OPIATE; OXYCODONE; OXYMORPHONE; SEDATIVE AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DEATH; DRUG ABUSE; DRUG OVERDOSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; RISK FACTOR; SCHOOL CHILD;

EID: 84855735170     PISSN: 15262375     EISSN: 15264637     Source Type: Journal    
DOI: 10.1111/j.1526-4637.2011.01260.x     Document Type: Article

References (46)

1. Centers for Disease Control and Prevention. WONDER [Online]. Centers for Disease Control and Prevention (producer). 2011. Available at: (accessed April 2010).
2. Paulozzi LJ, Logan JE, Hall AJ, etal. A comparison of drug overdose deaths involving methadone and other opioid analgesics in West Virginia. Addiction 2009;105:1541-8.
3. Warner M, Chen L, Makuc D. Increase in fatal poisonings involving opioid analgesics in the United States, 1999-2006. 2009. Available at: (accessed June 2011).
4. Mueller MR, Shah NG, Landen MG. Unintentional prescription drug overdose deaths in New Mexico, 1994-2003. Am J Prev Med 2006;30:423-9.
5. Lanier WA. Prescription opioid overdose deaths-Utah, 2008-2009. Epidemic Intelligence Service Conference. Atlanta, GA: Centers for Disease Control and Prevention, 2010.
6. Coolen P, Best S, Lima A, Sabel J, Paulozzi L. Overdose deaths involving prescription opioids among Medicaid enrollees-Washington, 2004-2007. MMWR Morb Mortal Wkly Rep 2009;58:1171-5.
7. Wunsch MJ. Prescription overdose deaths in rural Virginia. 2007. Available at: (accessed April 2010).
8. Shah N, Lathrop S, Reichard R, Landen M. Unintentional drug overdose death trends in New Mexico (USA), 1990-2005: Combinations of heroin, cocaine, prescription opioids and alcohol. Addiction 2008;103:126-36.
9. Cai R, Crane E, Poneleit K, Paulozzi L. Emergency department visits involving nonmedical use of selected prescription drugs-United States, 2004-2008. MMWR Morb Mortal Wkly Rep 2010;59:705-9.
10. Hall AJ, Logan JE, Toblin RL, etal. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA 2008;300:2613-20.
11. Paulozzi LJ, Budnitz DS, Xi Y. Increasing deaths from opioid analgesics in the United States. Pharmacoepidemiol Drug Saf 2006;15:618-27.
12. Weimer M, Wunsch M. Source of methadone in 2004 medical examiner drug deaths. 2007. Available at: (accessed June 2008).
13. Dunn KM, Saunders KW, Rutter CM, etal. Opioid prescriptions for chronic pain and overdose. Ann Intern Med 2010;152:85-92.
14. Braden JB, Russo J, Fan M-Y, etal. Emergency department visits among recipients of chronic opioid therapy. Arch Intern Med 2010;170:1425-32.
15. Martyres R, Cloade D, Burns JM. Seeking drugs or seeking help? Escalating "doctor shopping" by young heroin users before fatal overdose. Med J Aust 2004;180:211-4.
16. VonKorff M, Deyo RA. Potent opioids for chronic musculoskeletal pain: Flying blind? Pain 2004;109:207-0.
17. Ballantyne JC, Shin NS. Efficacy of opioids for chronic pain. Clin J Pain 2008;24:469-78.
18. Grady D, Berkowitz S, Katz MH. Opioids for chronic pain. Arch Intern Med 2011;171:1426-7.
19. U.S. Food and Drug Administration. National Drug Code Directory. Available at: (accessed August 2010).
20. Campbell KM, Deck D, Krupski A. A comparison of Link Plus, The Link King, and a "basic" deterministic algorithm. Health Informatics J 2008;14:5-15.
21. White AG, Birnbaum HG, Schiller M, Tang J, Katz NP. Analytic models to identify patients at risk for prescription opioid abuse. Am J Manag Care 2009;15:897-906.
22. Edlund MJ, Steffick D, Hudson T, Harris KM, Sullivan M. Risk factors for clinically recognized opioid abuse and dependence among veterans using opioids for chronic non-cancer pain. Pain 2007;129:355-62.
23. Wilsey BL, Fishman SM, Gilson AM, etal. Profiling multiple provider prescribing of opioids, benzodiazepines, stimulants, and anorectics. Drug Alcohol Depend 2010;112:99-106.
24. Katz N, Panas L, Kim M, etal. Usefulness of prescription monitoring programs for surveillance-Analysis of Schedule II opioid prescription data in Massachusetts, 1996-2006. Pharmacoepidemiol Drug Saf 2010;19:115-23.
25. Parente ST, Kim SS, Finch MD, etal. Identifying controlled substance patterns of utilization requiring evaluation using administrative claims data. Am J Manag Care 2004;10:783-90.
26. Goldberg GA. Identifying suboptimal management of persistent pain from integrated claims data: A feasibility study. Pharm Ther 2003;28:8-13.
27. Gammaitoni AR, Fine P, Alvarez N, McPherson M, Bergmark S. Clinical application of opioid equianalgesic data. Clin J Pain 2003;19:286-97.
28. Kelly JP, Cook SF, Kaufman DW, etal. Prevalence and characteristics of opioid use in the US adult population. Pain 2008;138:507-13.
29. Williams RE, Sampson TJ, Kalilani L, Wurzelmann JI, Janning SW. Epidemiology of opioid pharmacy claims in the United States. J Opioid Manag 2008;4:145-52.
30. Roe CM, McNamara AM, Motheral BR. Gender- and age-related prescription drug use patterns. Ann Pharmacother 2002;36:30-9.
31. Colliver JD, Kroutil LA, Dai L, Gfroerer JC. Rockville, MD: Substance Abuse and Mental Health Services Administration. 2006.
32. Inciardi JA, Surratt HL, Kurtz SP, Cicero TJ. Mechanisms of prescription drug diversion among drug-involved club- and street-based populations. Pain Med 2007;8:171-83.
33. Coolen P. Patient Review and Coordination Program. 2009. Available at: (accessed March 2010).
34. Hays L, Kirsh KL, Passik SD. Seeking drug treatment for OxyContin abuse: A chart review of consecutive admissions to a substance abuse treatment facility in Kentucky. J Natl Compr Canc Netw 2003;1:423-8.
35. Bohnert AS, Valenstein M, Bair MJ, etal. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 2011;305:1315-21.
36. Gomes T, Juurlink DN, Dhalla IA, etal. Trends in opioid use and dosing among socio-economically disadvantaged patients. Open Med 2011;5:E13-22.
37. Portenoy RK, Foley KM. Chronic use of opioid analgesics in non-malignant pain: Report of 38 cases. Pain 1986;25:171-86.
38. Washington State Agency Medical Directors' Group. Interagency guideline on opioid dosing for chronic non-cancer pain. Available at: (accessed March 2008).
39. Sundwall DN, Rolfs RT, Johnson E. Utah clinical guidelines on prescribing opioids for treatment of pain. 2009. Available at: (accessed February 2010).
40. Walsh SL, Preston KL, Stitzer ML, Cone EJ, Bigelow GE. Clinical pharmacology of buprenorphine: Ceiling effects at high doses. Clin Pharmacol Ther 1994;55:569-80.
41. Ravndal E, Amundsen EJ. Mortality among drug users after discharge from inpatient treatment: An 8-year prospective study. Drug Alcohol Depend 2009;108:65-9.
42. Webster LR, Cochella S, Dasgupta N, etal. An analysis of the root causes for opioid-related overdose deaths in the United States. Pain Med 2011;12:S26-35.
43. Dasgupta N, Kramer E, Zalman M, etal. Association between non-medical and prescriptive use of opioids. Drug Alcohol Depend 2006;82:135-42.
44. Butler SF, Fernandez KC, Chang A, etal. Measuring attractiveness for abuse of prescription opioids. Pain Med 2010;11:67-80.
45. Dormitzer C. Summary of drug abuse "rates" in the United States. 2008. Available at: (accessed January 2010).
46. Katz N, Houle B, Fernandez KC, etal. Update on prescription monitoring in clinical practice: A survey study of prescription monitoring program administrators. Pain Med 2008;9:587-94.